metaPreg - Tenofovir (local routes) during pregnancy

Tenofovir (local routes)

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Growth parameters and prematurity
Preterm (< 37 weeks)	0.44 [0.04, 4.71]	-	1 study	4	16	not evaluable	ROB	-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	-	-	0 study					-
Postpartum hemorrhage	-	-	0 study					-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Fetal distress	-	-	0 study					-
Neonatal death (< 28 days of life)	0.18 [0.01, 3.75]	-	1 study	3	16	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine death (< 22 weeks)	0.54 [0.12, 2.38]	-	1 study	10	22	not evaluable	ROB	-
Elective/induced termination of pregnancy	1.47 [0.27, 8.09]	-	1 study	6	22	not evaluable	ROB	-
Late intrauterine deaths (> 22 weeks)	1.42 [0.03, 74.32]	-	1 study		22	not evaluable	ROB	-
Hide endpoints reported in only one study ...